Immix Biopharma, Inc. Increase Decrease In Operating Lease Liability
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-07
- Immix Biopharma, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$35.98K.
- Immix Biopharma, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$35.23K.
- Immix Biopharma, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$33.37K.
- Immix Biopharma, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$32.67K.
- Immix Biopharma, Inc. increase decrease in operating lease liability for fiscal 2025 was -$98.01K, a 3536.40% decline from fiscal 2024.
- Immix Biopharma, Inc. increase decrease in operating lease liability for fiscal 2024 was $2.85K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$35.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$71.21K 10-Q · filed 2026-08-07 | -$104.58K derived: sum of 3 quarters · filed 2026-08-07 | -$137.25K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$35.23K 10-Q · filed 2026-05-07 | -$68.60K derived: sum of 2 quarters · filed 2026-05-07 | -$101.27K derived: sum of 3 quarters · filed 2026-05-07 | -$117.41K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$33.37K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-03-27 | -$66.04K derived: sum of 2 quarters · filed 2026-03-27 | -$82.18K derived: sum of 3 quarters · filed 2026-08-07 | -$98.01K 10-K/A · filed 2026-03-27 |
| 2025-09-30 | -$32.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$48.81K derived: sum of 2 quarters · filed 2026-08-07 | -$64.64K 10-Q · filed 2025-11-07 | -$78.92K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$16.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$31.97K 10-Q · filed 2026-08-07 | -$46.25K derived: sum of 3 quarters · filed 2026-08-07 | -$48.36K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$15.83K 10-Q · filed 2026-05-07 | -$30.11K derived: sum of 2 quarters · filed 2026-05-07 | -$32.22K derived: sum of 3 quarters · filed 2026-05-07 | -$34.28K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$14.29K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-03-27 | -$16.39K derived: sum of 2 quarters · filed 2026-03-27 | -$18.46K derived: sum of 3 quarters · filed 2026-03-27 | $2.85K 10-K/A · filed 2026-03-27 |
| 2024-09-30 | -$2.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.17K derived: sum of 2 quarters · filed 2025-11-07 | $17.14K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | -$2.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $19.24K 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $21.31K 10-Q · filed 2025-05-08 |